切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (06) : 678 -681. doi: 10.3877/cma.j.issn.1674-3946.2025.06.022

论著

MMIF与围手术期指标预测甲状腺全切术后甲状旁腺功能减退的价值
孟竹达(), 靳亚杰, 郝冉, 赵二鹏   
  1. 046000 山西长治,长治市人民医院甲状腺外科
  • 收稿日期:2025-05-20 出版日期:2025-12-26
  • 通信作者: 孟竹达

Value of MMIF and perioperative indicators in predicting hypoparathyroidism after total thyroidectomy

Zhuda Meng(), Yajie Jin, Ran Hao, Erpeng Zhao   

  1. Department of Thyroid Surgery, Changzhi People’s Hospital, Changzhi Shaanxi Province046000, China
  • Received:2025-05-20 Published:2025-12-26
  • Corresponding author: Zhuda Meng
  • Supported by:
    Basic Research Project of Shanxi Province(20210302124289)
引用本文:

孟竹达, 靳亚杰, 郝冉, 赵二鹏. MMIF与围手术期指标预测甲状腺全切术后甲状旁腺功能减退的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 678-681.

Zhuda Meng, Yajie Jin, Ran Hao, Erpeng Zhao. Value of MMIF and perioperative indicators in predicting hypoparathyroidism after total thyroidectomy[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(06): 678-681.

目的

分析甲状腺全切除术患者血清巨噬细胞移动抑制因子(MMIF)联合围手术期相关指标[白介素-6(IL-6)、甲状旁腺激素(PTH)]对术后早期甲状旁腺功能减退的预测价值。

方法

前瞻性选取2021年1月至2025年1月行甲状腺全切除术的130例患者为研究对象,依据术后1个月空腹血钙水平(指离子钙[1])分为甲状旁腺功能减退组(n=40,血钙水平<2.1mmol/L)和正常组(n=90,血钙水平≥2.1mmol/L)。以Logistic回归分析构建了以MMIF、IL-6、PTH为变量的联合预测模型,采用受试者工作特征曲线(ROC)分析术后MMIF、IL-6、PTH水平对早期甲状旁腺功能减退的预测价值。

结果

甲状旁腺功能减退组患者术后MMIF、IL-6水平高于正常组,PTH水平低于正常组(P<0.05)。Logistic回归分析显示,术后MMIF、IL-6、PTH是甲状旁腺功能减退的预测指标,联合预测模型为Logit (P)=-4.440+2.178×MMIF+0.189×IL-6-0.257×PTH。ROC曲线显示,MMIF、IL-6、PTH联合预测术后早期甲状旁腺功能减退的曲线下面积(AUC)为0.892,灵敏度为82.5%,特异度为92.2%,联合预测效能优于各指标单独预测(P<0.05)。

结论

甲状腺全切除术患者术后MMIF、IL-6、PTH水平对术后早期甲状旁腺功能减退具有一定的预测价值,且三者联合检测可提高其预测效能。临床上可考虑在术后早期筛查上述指标,及时采取防治措施,以减轻甲状旁腺功能损伤。

Objective

To analyze the predictive value of serum macrophage migration inhibitory factor (MMIF) combined with perioperative indicators [interleukin-6 (IL-6), parathyroid hormone (PTH)] for early postoperative hypoparathyroidism in patients undergoing total thyroidectomy.

Methods

A prospective study was conducted on 130 patients who underwent total thyroidectomy from January 2021 to January 2025. All patients were followed up postoperatively and divided into the hypoparathyroidism group (n=40, serum calcium level <2.1mmol/L) and the normal group (n=90, serum calcium level ≥2.1mmol/L) based on fasting serum calcium levels (referring to ionized calcium[1]) at 1 month after surgery. A combined prediction model with MMIF, IL-6, and PTH as variables was constructed using Logistic regression analysis. Receiver operating characteristic (ROC) curves were used to analyze the predictive value of postoperative MMIF, IL-6, and PTH levels for early hypoparathyroidism.

Results

The levels of postoperative MMIF and IL-6 in the hypoparathyroidism group were higher than those in the normal group, while the PTH level was lower (P<0.05). Logistic regression analysis showed that postoperative MMIF, IL-6, and PTH were predictive indicators of hypoparathyroidism, and the combined prediction model was Logit(P) = -4.440 + 2.178 × MMIF + 0.189 × IL-6 - 0.257 × PTH. ROC curve analysis revealed that the area under the curve (AUC) of the combined prediction of early postoperative hypoparathyroidism by MMIF, IL-6, and PTH was 0.892, with a sensitivity of 82.5% and a specificity of 92.2%. The combined prediction efficacy was superior to that of each indicator alone (P<0.05).

Conclusion

Postoperative MMIF, IL-6, and PTH levels in patients undergoing total thyroidectomy have certain predictive value for early postoperative hypoparathyroidism, and the combined detection of the three can improve the predictive efficacy. Clinically, early postoperative screening of these indicators may be considered, and timely prevention and treatment measures can be taken to reduce parathyroid function damage.

表1 两组行甲状腺全切除术患者一般资料比较
表2 两组行甲状腺全切除术患者术后血清MMIF、IL-6、PTH水平比较(±s
表3 基于Logistic回归分析构建MMIF、IL-6、PTH联合预测的模型
图1 血清MMIF、IL-6、PTH联合预测甲状腺全切除术患者术后早期甲状旁腺功能减退的ROC曲线图
表4 血清MMIF、IL-6、PTH联合预测甲状腺全切除术患者术后早期甲状旁腺功能减退的效能分析
[1]
梅长利, 李学文, 那将超, 等. 术后血清MMIF, IL-6及PTH水平与甲状腺乳头状癌术后甲状旁腺功能减退的相关性[J]. 分子诊断与治疗杂志, 2024, 16(01): 170-173.
[2]
Fernández-Baeza M, Muñoz-Pérez NV, Roldán-Ortiz I, et al. Predictive Factors of Athyroglobulinemia After Total Thyroidectomy for Papillary Thyroid Cancer [J]. Cancers (Basel), 2024, 16(24): 4129.
[3]
中国研究型医院学会甲状旁腺及骨代谢疾病专业委员会, 中华医学会骨质疏松和骨矿盐疾病分会. 术后甲状旁腺功能减退症管理专家共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2025, 18(01): 1-12.
[4]
Mannstadt M, Cianferotti L, Gafni RI, et al. Hypoparathyroidism: Genetics and Diagnosis [J]. J Bone Miner Res, 2022, 37(12): 2615-2629.
[5]
Kong YZ, Chen Q, Lan HY. Macrophage Migration Inhibitory Factor (MIF) as a Stress Molecule in Renal Inflammation [J]. Int J Mol Sci, 2022, 23(9): 4908.
[6]
沈娟娟, 哈丽亚·哈力木别克, 王登兰, 等. 妊娠期亚临床甲状腺功能减退患者血清IL-6, TNF-α, IGF-1水平与血脂,甲状腺功能和妊娠结局的关系[J]. 疑难病杂志, 2023, 22(02): 176-181.
[7]
Khan AA, Rubin MR, Schwarz P, et al. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial [J]. J Bone Miner Res, 2023, 38(1): 14-25.
[8]
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021[J]. 肿瘤预防与治疗, 2021, 34(12): 1164-1200.
[9]
Edwards ER, Hazkani I, Stein E, et al. Total Thyroidectomy and Subsequent Weight Gain in Pediatric Populations [J]. Laryngoscope, 2023, 133(6): 1518-1523.
[10]
林贝, 周天晗, 周力, 等. 甲状腺乳头状癌甲状腺全切除术后甲状旁腺功能减退的影响因素及恢复时间分析 [J]. 浙江医学, 2023, 45(10): 1030-1035.
[11]
陈飞, 李浪. 西那卡塞联合阿法骨化醇冲击疗法对维持性血液透析并发继发性甲状旁腺功能亢进症的治疗效果及其对甲状旁腺功能,钙磷代谢紊乱情况,炎症水平的影响[J]. 临床内科杂志, 2024, 41(10): 715-717.
[12]
Yoon C, Kim HK, Ham YS, et al. Toxoplasma gondii macrophage migration inhibitory factor shows anti-Mycobacterium tuberculosis potential via AZIN1/STAT1 interaction [J]. Sci Adv, 2024, 10(43): eadq0101.
[13]
张亚冰, 徐国辉, 宋韫韬, 等. 甲状腺全切除术后甲状旁腺功能减退的相关危险因素分析[J]. 中华普通外科杂志, 2022, 37(09): 679-683.
[14]
那将超, 狄长安. 甲状腺乳头状癌患者术后血清MMIF和IL-6表达水平与甲状旁腺功能减退持续时间的相关性研究[J]. 现代检验医学杂志, 2023, 38(01): 191-194.
[15]
高金伟, 张琪, 王泽升, 等. 甲状腺乳头状癌术后第1天甲状旁腺激素水平对永久性甲状旁腺功能减退的预测价值[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(05): 365-369.
[16]
Salama RM, Omar MA. Anti-aging effect of nifuroxazide on skin changes of aged male rat models via modulating immunoreactivity of IL-6/NF-κB/Caspase-3[J]. Morphologie, 2023, 107(359): 100605.
[17]
李娟, 罗婷, 蒲柯, 等. 急性胰腺炎相关性甲状腺损伤发生机制研究进展[J]. 山东医药, 2024, 64(32): 100-103.
[18]
孙辉, 李长霖. 分化型甲状腺癌根治性切除术中的关键考量与策略[J/CD]. 中华普外科手术学杂志(电子版), 2024, 18(05): 477-481.
[1] 管豪, 李小容, 张瑶, 任明针. 不同年龄难治性肺炎支原体肺炎患儿高迁移率族蛋白B1水平差异及对转归的预测价值[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(02): 104-115.
[2] 王小贝, 吕庆福, 倪婷. 免充气腋窝入路与全乳晕入路腔镜下甲状腺癌根治术的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 368-371.
[3] 董家旭, 宋美姿, 毕讯. 射频消融术联合TSH抑制治疗甲状腺微小乳头状癌的效果及生存预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 200-203.
[4] 孙建, 赵明慧, 赵恩春, 刘威辰. 经胸乳入路腔镜手术治疗甲状腺癌的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 204-207.
[5] 王伟伟, 费建平, 王璋瑜. 不同手术空间建立方法的经口腔前庭入路腔镜甲状腺术对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 84-87.
[6] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[7] 宋红霞, 吴玩呈. 内镜下甲状腺手术切口入路发展的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 470-472.
[8] 何羽. 腔镜微创手术治疗分化型甲状腺癌的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 456-458.
[9] 游涛建, 任林, 马宇. cT1-2N0期PTMC经口腔前庭入路腔镜甲状腺切除术后引流与否的可行性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 311-314.
[10] 张晓红, 李新, 赵荣华, 韩宁宁. 血清骨膜蛋白水平对咳嗽变异性哮喘患儿治疗反应性的预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(04): 638-642.
[11] 张春玉, 陈海云, 肖忠萍, 罗琴, 潘运昌. 血清NT-proBNP 预测肺栓塞心脏功能障碍的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 805-808.
[12] 王春莹, 江永强, 韩海静, 苏红霞, 李转, 党飞, 折彤, 屈耀宁. 血清SAA、sIL-2R水平与内镜逆行胰胆管造影术后胰腺炎严重程度的相关性及预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 46-50.
[13] 张强, 孙如初, 梁璐. 困难气道生理评分对急诊生理性困难气道的预测价值[J/OL]. 中华临床医师杂志(电子版), 2025, 19(01): 20-26.
[14] 吴敏, 陈志刚, 邱晨, 樊冬雪. 院前休克指数对创伤患者预后预测价值分析[J/OL]. 中华卫生应急电子杂志, 2025, 11(01): 6-9.
[15] 李小勇, 郭海志, 赵洋. QSM 联合SWI 预测急性缺血性脑卒中患者EVT 后神经功能的价值[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(06): 549-555.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?